CoChat

Tumor–stroma co-evolution in prostate cancer progression and metastasis

Open access
Josson, Sajni, Matsuoka, Yasuhiro, Chung, Leland W.K., Zhau, Haiyen E., Wang, Ruoxiang · 2010 · Seminars in Cell & Developmental Biology
Cited by 137

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Cancer development is complex and involves several layers of interactions and pleotropic signalling mechanisms leading to progression. Cancer cells associate with resident stromal fibroblasts, smooth muscle cells, macrophages, endothelium, neurons and migrating cells at metastatic sites and phenotypically and genotypically activate them. These become an integral part of the cancer cell community through activated cell signalling mechanisms. During this process, the cancer cells and cells in the cancer microenvironment “co-evolve” in part due to oxidative stress, and acquire the ability to mimic other cell types (which can be termed osteomimicry, vasculomimicry, neuromimicry and stem cell mimicry), and undergo transition from epithelium to mesenchyme with definitive behavioral modifications. In our laboratory, we demonstrated that prostate cancer cells co-evolve in their genotypic and phenotypic characters with stroma and acquire osteomimetic properties allowing them to proliferate and survive in the skeleton as bone metastasis. Several signalling interactions in the bone microenvironment, mediated by reactive oxygen species, soluble and membrane bound factors, such as superoxide, β2microglobulin and RANKL have been described. Targeting the signalling pathways in the cancer-associated stromal microenvironment in combination with known conventional therepeutic modalities could have a synergistic effect on cancer treatment. Since cancer cells are constantly interacting and acquiring adaptive and survival changes primarily directed by their microenvironment, it is important to delineate these interactions and co-target both cancer and stroma to improve the treatment and overall survival of cancer patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.semcdb.2009.11.016

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 137

Metadata

Authors
Josson, S., Matsuoka, Y., Chung, L. W. K., Zhau, H. E., & Wang, R.
Venue
Seminars in Cell & Developmental Biology
Publisher
Elsevier BV
Published
2010-02
Volume
21
Issue
1
Pages
26-32
ISSN
1084-9521 (ISSN-L)
OpenAlex
W2046701189
Cited by
137
References
4
FWCI
9.15
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tumor–stroma co-evolution in prostate cancer progression and metastasis. https://app.cochat.ai/papers/10.1016/j.semcdb.2009.11.016
The paper
Josson, S., Matsuoka, Y., Chung, L. W. K., Zhau, H. E., & Wang, R. (2010). Tumor–stroma co-evolution in prostate cancer progression and metastasis. Seminars in Cell & Developmental Biology. https://doi.org/10.1016/j.semcdb.2009.11.016

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.